Moody Lynn & Lieberson, LLC Moderna, Inc. Transaction History

Moody Lynn & Lieberson, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$118.38 - $210.04 $619,127 - $1.1 Million	5,230 New	5,230 $939,000
Q4 2021 Jan 26, 2022	SELL	$225.82 - $368.51 $180,656 - $294,808	-800 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$221.9 - $484.47 $39,498 - $86,235	-178 Reduced 18.2%	800 $308,000
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $127,051 - $229,810	978 New	978 $230,000
Q1 2020 Apr 30, 2020	SELL	$17.78 - $31.58 $1.44 Million - $2.55 Million	-80,820 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$13.93 - $21.28 $1.13 Million - $1.72 Million	80,820 New	80,820 $1.58 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.